You have to make sure that the Forex software package that you select has done well in back testing and in live trading. You have to research the software and make sure that other...

Tags:

Redwood Unveils Marijuana Tests

Redwood Toxicology Laboratory, a subsidiary of Inverness Medical Innovations (IMA), recently announced new lab testing to detect JWH-018 and JWH-073 metabolites in urine samples. These are the main sy...

Tags:

General Dynamics Gets Contract

General Dynamics Land Systems – Canada, a business unit of General Dynamics Corporation (NYSE:GD), has got a $34.4 million Canadian contract. Under this contract, General Dynamics will perform trade...

Tags:

The European Union (EU) bank stress tests failed to account for a sovereign default, meaning results show a healthier banking sector than actually exists. The tests results were released Friday with ...

Tags:

CSCX Starts Diagnostic Workstation

Recently, Cardiac Science Corporation (NASDAQ:CSCX) initiated CareCentre MD, a diagnostic workstation that further expands its ECG and cardiac stress product portfolio. It is the first multimodular PC...

Tags:

USD/JPY: Anticipating Another Rally Swing to 87.70

A little recap first; USD/JPY bounced from 87, but fell after testing 89. The market is supported here above 86.26, but I suspect some further decline towards…7 Vote(s) ...

Tags:

Radient To Buy Provista

Radient Pharmaceuticals Corporation (RPC) recently announced a letter of intent to take over Provista Diagnostics, a Phoenix-based biotech company, developing tests for rapid disease detection. It is ...

Tags:

Recall Of CPHD’s Xpert MRSA/SA

Recently, Cepheid (NASDAQ:CPHD) recalled its blood culture (”BC”) testing product, Xpert MRSA/SA, as it was generating false MRSA negative results, implying that wrong treatment was being ...

Tags:

BP’s First Successful Cap On Leak

In an initial phase of testing, BP Plc (NYSE:BP) has successfully checked the leakage at its Deepwater Horizon rig that exploded and sank in April. The sealing of the leakage comes as a much-awaited m...

Tags:

Testing Times For Glaxo’s Avandia

GlaxoSmithKline, plc (NYSE:GSK) recently announced that the risk-benefit profile of its diabetes drug Avandia will be reviewed by the European Medicines Agency’s (EMA) Committee for Medicinal Produc...

Tags: